Study shows consuming antidepressants during pregnancy can lead to autism in child
Women who consume antidepressants during their last two trimesters of pregnancy are more likely to bear a child who has chances of being diagnosed with autism spectrum disorder, according to a new study. Scientists have observed that children diagnosed with autism were three times more expected to have been exposed to antidepressants in the womb. This research was published in the JAMA Pediatrics and it has emerged as one of the strongest findings that associate the use of antidepressant during pregnancy to poor consequences in children that are born out of those pregnancies.
1 Fetus exposed to antidepressants is vulnerable to developmental delays
The study has found out that those children whose mothers took drugs like Lexapro, Celexa, Prozac, Praxil and Zoloft during their pregnancy trimesters were more vulnerable to suffer from developmental delays. Such drugs better known as SSRIs are a threat to the fetus if consumed by the expecting mother.
Study co-author and associate scientist Li Ching Lee has said that prenatal exposure to SSRI during the second and third trimester is more likely to hit the child with vulnerability to autism in life than those exposed to SSRI during the first trimester.
2 Negative impact on both the mother and the child
This study has given an in-depth look to Canadian births, the use of antidepressants and their influence on mother and child. Though the results are indeed controversial in nature they are guaranteed to flash a debate.
It must be noted that the study authors have also pointed risk to both the mother and unborn fetus from even untreated depression. Dr Lee has further affirmed that it is a really complex decision to make, whether depression during pregnancy should be treated with medications or not. After all, there are a multitude of factors to be considered. Researchers do not intend that the study should be used as a basis for decisions related to medical treatments.